KORU Medical Systems, Inc. (KRMD)
NASDAQ: KRMD · Real-Time Price · USD
4.390
+0.180 (4.28%)
Mar 23, 2026, 2:11 PM EDT - Market open
KORU Medical Systems Revenue
In the year 2025, KORU Medical Systems had annual revenue of $41.13M with 22.23% growth. KORU Medical Systems had revenue of $10.90M in the quarter ending December 31, 2025, with 23.27% growth.
Revenue (ttm)
$41.13M
Revenue Growth
+22.23%
P/S Ratio
4.90
Revenue / Employee
$563,389
Employees
73
Market Cap
203.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 41.13M | 7.48M | 22.23% |
| Dec 31, 2024 | 33.65M | 5.13M | 17.98% |
| Dec 31, 2023 | 28.52M | 621.63K | 2.23% |
| Dec 31, 2022 | 27.90M | 4.41M | 18.76% |
| Dec 31, 2021 | 23.49M | -686.27K | -2.84% |
| Dec 31, 2020 | 24.18M | 1.01M | 4.38% |
| Dec 31, 2019 | 23.16M | 5.81M | 33.47% |
| Dec 31, 2018 | 17.35M | 1.91M | 12.37% |
| Dec 31, 2017 | 15.44M | 2.47M | 19.07% |
| Sep 30, 2017 | 12.97M | 675.99K | 5.50% |
| Feb 28, 2017 | 12.29M | 46.32K | 0.38% |
| Feb 29, 2016 | 12.25M | 1.00M | 8.92% |
| Feb 28, 2015 | 11.24M | 2.55M | 29.27% |
| Feb 28, 2014 | 8.70M | 934.90K | 12.04% |
| Feb 28, 2013 | 7.76M | 1.37M | 21.49% |
| Feb 29, 2012 | 6.39M | 1.47M | 29.87% |
| Feb 28, 2011 | 4.92M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Embecta | 1.08B |
| AngioDynamics | 307.31M |
| OraSure Technologies | 115.02M |
| Sanara MedTech | 101.88M |
| Harvard Bioscience | 86.55M |
| Pro-Dex | 72.10M |
| Utah Medical Products | 38.52M |
| Stereotaxis | 32.38M |
KRMD News
- 10 days ago - KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility - Business Wire
- 10 days ago - KORU Medical Systems, Inc. (KRMD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - KORU Medical Systems Announces CEO Transition - Business Wire
- 10 days ago - KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance - Business Wire
- 24 days ago - KORU Medical Systems to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 - Business Wire
- 7 weeks ago - KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System - Business Wire
- 2 months ago - KORU Medical Systems Reports Preliminary Q4 and Full Year 2025 Results; Achieves Record Revenue and Full Year Positive Operating Cash Flow - Business Wire
- 2 months ago - KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire